Andy Dillin: Using aging research to probe biology by Sedwick, Caitlin
People & Ideas
JCB • VOLUME 189 • NUMBER 4 • 2010 616
A
s time passes, cells accumulate 
damage to genetic, protein, and 
lipid components, causing cel-
lular aging and eventually death. Cells 
have extensive damage-mitigation path-
ways, but just what these pathways are, 
and how and when they operate, is still 
under investigation.
Andy Dillin is fascinated by these 
questions, but came to studying them in a 
roundabout way. He got his fi  rst taste of 
research in Ardythe McCracken’s lab at 
the University of Nevada, Reno (1), and 
developed an addiction to science that 
only grew during his graduate studies in 
genetics with Jasper Rine’s group at 
Berkeley (2). He found his true obsession 
after joining Cynthia Kenyon’s lab, where 
he leveraged the power of C. elegans to 
explore the connection between metabo-
lism and aging (3).
Dillin’s own lab at the Salk Research 
Institute is working to understand how the 
cellular pathways that affect the rate of 
aging are triggered and integrated (4, 5). 
We sat down with him in his offi  ce over-
looking the Pacifi  c Ocean to chat about 
young scientists and aging cells.
REVELATION IN RESEARCH
What got you interested in science?
I grew up in Reno, and my high school 
chemistry teacher there, Mr. 
Wilcox, is the person who 
turned me on to science. I 
was failing every other 
class, but he took me under 
his wing and showed me 
that I could actually be a 
good student. I guess from 
then on I always knew I 
wanted to do science.
As an undergraduate, I got a job as a 
technician and research assistant in Ar-
dythe McCraken’s lab at the University of 
Reno, Nevada. When I joined her lab, 
Ardythe was transitioning from tissue 
culture to yeast. We were all wrestling 
with this bizarre phenomenon where we 
would put an unfolded protein into the 
endoplasmic reticulum (ER) and it would 
get degraded in the cytosol. I worked on 
this as my undergraduate thesis, and fi  g-
ured out some of the mechanism. But it 
wasn’t until after I left that Ardythe and her 
graduate student, Eric Werner, really fi  g-
ured it out. They, along with Jeff Brodsky 
at Pittsburgh, are the ones who coined the 
term ERAD (ER-associated degradation), 
which of course is widely used now.
Ardythe’s a great mentor. She showed 
me that you can have a balanced lifestyle 
and do great science. You can be at a 
small university and make an impact on 
the bigger world.
So graduate school was a natural next 
step for you?
Yes. I was in love with Randy Schekman’s 
work, so I applied to and was accepted at 
Berkeley. I rotated in Randy’s lab and was 
offered a place there, but I had one more 
rotation to do before I could join. I de-
cided to try out genetics, about which I 
knew little at the time. I rotated in Jasper 
Rine’s lab and fell in love with the ap-
proach. I stayed there for my PhD, study-
ing DNA replication and transcriptional 
silencing. Jasper’s lab co-discovered the 
eukaryotic replication initiator. It gave us 
a lot of insights into how DNA replicates, 
and it was neat to see a whole 
fi  eld open up around it.
Jasper was also an im-
portant mentor for me. He 
taught me how to think criti-
cally about scientifi  c results, 
and how to communicate 
about them effectively.
DISTRESSING DISCOVERIES
But as a postdoc you made a big jump 
in your research—into the aging ﬁ  eld?
I thought a long time about what I wanted to 
do as a postdoc but I had a hard time settling 
on something. I would think about it all 
day then go home every night, and I’d watch 
whatever was on the Discovery Channel. 
I was a total junkie for it; I think that sub-
consciously I was watching it to fi  gure out 
what I wanted to do as a postdoc. I got 
several ideas from this, but for one reason 
or another most of them didn’t pan out. At 
one point I was thinking about schizo-
phrenia, which is a multigenic trait that 
would be really hard to study. I thought I 
might as well study something equally 
complicated, like aging! So I started look-
ing into that, and found that Cynthia 
Kenyon’s lab had discovered a single gene 
that could change an animal’s life span. 
Her work showed that you can apply sim-
ple genetics to a complex trait—and I 
knew that was what I wanted to work on.
In Cynthia’s lab, you pioneered the use 
of RNAi for large-scale screens and 
conditional gene expression in C. elegans?
That screen saved my postdoc. I was so 
naïve. When I went to Cynthia’s lab, the 
textbooks all said you start aging from the 
day you’re born until the day you die. And 
I said, “Is that really true?” If that were 
true, then the genetic pathway that controls 
aging should be functioning that whole 
time. But it was possible that instead, there 
could be critical windows that control 
aging. I spent an entire year trying to set up 
an inducible expression system in the 
worm to test for these windows, but I got 
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zero positive results. Thank God for Lisa 
Timmons, who was in Andy Fire’s lab. 
Double-stranded RNA was known to 
interfere with gene expression, but she’d 
discovered that you could feed worms 
bacteria producing this double-stranded 
RNA. That gave us a means to control the 
timing of gene inactivation, and later we 
also fi  gured out how to inactivate the ma-
chinery that allows RNAi to work in the 
fi  rst place. Using this system, we found 
that the worm doesn’t start 
aging from the day it’s born 
until the day it dies. Actu-
ally, we found a pathway 
that only works during a 
four-day window in the 
animal’s life span, during 
reproductive adulthood.
As an additional project 
I set up a genomic screen 
to identify new genes that 
affected the aging process. 
Initially, I was concerned 
when my screen pulled out many nuclear-
encoded mitochondrial genes. Cynthia’s 
and Gary Ruvkun’s work with insulin sig-
naling had already pointed to a role for 
metabolism in aging, and I didn’t want to 
end up competing with them in my own 
work. But it looked like I was going to be 
writing a paper on metabolism, after all. 
The classic metabolic theory of aging says 
that reactive oxygen species (ROS) cause 
accumulating damage throughout life. 
Therefore, if you can reduce metabolism 
(and ROS production), you should be able 
to increase lifespan by an amount propor-
tional to the amount of time you decrease 
metabolism. I decided to take a closer 
look at this and found that the picture’s 
more complicated. In fact, insulin signal-
ing affects aging throughout reproductive 
adulthood, but this new mitochondrial 
pathway is something sepa-
rate that affects aging only 




Since arriving at the Salk 
in 2002, what have you 
been working on?
Going back to my early fas-
cination with protein folding 
that I developed in Ardythe’s 
lab, we have turned our attention to how 
the proteome is protected during aging. 
We have made some neat discoveries 
about how toxic proteins are dealt with 
and followed this body of work into mice 
and human cells.
The other part of my lab works on the 
genetic circuitry of aging itself. We can talk 
of three major pathways that affect aging: 
the insulin pathway, the mitochondrial path-
way, and a separate pathway activated by 
dietary restriction. We’re concentrating on 
the last two of these. My lab has uncovered 
the genetic pathway that regulates dietary 
restriction and we are making equally excit-
ing headway on the mitochondrial pathway. 
But it has not escaped our attention that all 
three of these pathways affect metabolism, 
leading us to ask: what aspects of metabo-
lism promote healthiness? We’re fi  nding 
that metabolism is somehow feeding into 
the fidelity of proteome maintenance, 
thereby linking the efforts of all parts of the 
lab. Our thinking now is that when cells are 
stressed metabolically—not to the break-
ing point, but mildly stressed—they say, 
“If we’re going to go to the effort to actu-
ally make a protein, we’re going to make 
very sure that it folds properly because we 
don’t have the resources to try again.” 
This  leads to changes in chaperone net-
works, improved proofreading processes on 
all levels, and better cell and organismal 
health. Of course, on a population level such 
stress is undesirable, because if you’re 
stressed you’re not too interested in breed-
ing. But from the individual cell’s or organ-
ism’s standpoint it’s a nice thing to live 
longer and more healthfully.
How do you keep healthy personally?
Well, fi  rst I make sure to keep my science 
addiction well fed at work. Then, I ride my 
bike to keep fi  t, although I no longer race 
like I did when I was at the University of 
Reno. I also spend a lot of time working on 
my house; I’ve renovated every house I’ve 
ever lived in. I’m currently building a wine 
cellar in my home, because I have two 
partners in the Bay Area, Raul Andino and 
Judith Frydman, with whom I’ve been 
making wine. We make about 700 bottles a 
year up there, and I’m putting a fermen-
tation facility in my cellar so that I can 
make wine here, too. It’ll be an interesting 
experiment, to see how differently it turns 
out from our Bay Area stuff!
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Dillin sheltering from UV stress.